Trials / Completed
CompletedNCT00756990
Depot Naltrexone Treatment of Opioid Dependent Parolees
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 61 (actual)
- Sponsor
- University of Pennsylvania · Academic / Other
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
This is an investigation involving the use of a long-acting, injectable form (depot) of naltrexone as a treatment for persons who have a history of opioid dependence, with up to 40 on parole/probation and 20 non-parolees. The test is a pilot study of up to 60 subjects treated with 6 months of depot naltrexone plus Psychosocial Treatment .
Detailed description
This is a two phase study. Phase 1 is complete and phase 2 is not yet recruiting.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Depot Naltrexone | 228mg of injectable naltrexone |
Timeline
- Start date
- 2005-11-01
- Primary completion
- 2009-03-01
- Completion
- 2011-08-01
- First posted
- 2008-09-22
- Last updated
- 2019-04-23
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00756990. Inclusion in this directory is not an endorsement.